Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-432773
Filing Date
2013-11-07
Accepted
2013-11-07 16:03:19
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d585589d10q.htm 10-Q 250150
2 EX-31.1 d585589dex311.htm EX-31.1 7686
3 EX-31.2 d585589dex312.htm EX-31.2 7683
4 EX-32.1 d585589dex321.htm EX-32.1 4085
5 EX-32.2 d585589dex322.htm EX-32.2 4082
  Complete submission text file 0001193125-13-432773.txt   3047765

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nviv-20130930.xml EX-101.INS 312720
7 XBRL TAXONOMY EXTENSION SCHEMA nviv-20130930.xsd EX-101.SCH 43173
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nviv-20130930_cal.xml EX-101.CAL 55058
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nviv-20130930_def.xml EX-101.DEF 94261
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20130930_lab.xml EX-101.LAB 306046
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20130930_pre.xml EX-101.PRE 206405
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52089 | Film No.: 131200568
SIC: 3841 Surgical & Medical Instruments & Apparatus